← Back to VRTX

VERTEX PHARMACEUTICALS INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSSep 2026Filed 03/11/2026Jun 2026Filed 04/08/2026Mar 2026Filed 05/05/2026Sep 2025Filed 03/11/2026Jun 2025Filed 04/08/2026Mar 2025Filed 05/05/2026Sep 2024Filed 04/11/2025Jun 2024Filed 05/08/2025
$3,441$3,334$2,987$3,076$2,965$2,770$2,772$2,646
$654$1,100$1,031$1,083$1,033$646$1,045−$3,594
$2.56$4.31$4.02$4.20$3.99$2.49$4.01−$13.92
255255256258259260261258

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.